244 related articles for article (PubMed ID: 31588875)
1. Pharmacogenetics and the treatment of epilepsy: what do we know?
Božina N; Sporiš IŠ; Božina T; Klarica-Domjanović I; Tvrdeić A; Sporiš D
Pharmacogenomics; 2019 Oct; 20(15):1093-1101. PubMed ID: 31588875
[TBL] [Abstract][Full Text] [Related]
2. The interface of preclinical evaluation with clinical testing of antiepileptic drugs: role of pharmacogenomics and pharmacogenetics.
Holmes GL
Epilepsy Res; 2002 Jun; 50(1-2):41-54. PubMed ID: 12151116
[TBL] [Abstract][Full Text] [Related]
3. Various pharmacogenetic aspects of antiepileptic drug therapy: a review.
Mann MW; Pons G
CNS Drugs; 2007; 21(2):143-64. PubMed ID: 17284096
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and antiepileptic drugs.
Spear BB
Epilepsia; 2001; 42 Suppl 5():31-4. PubMed ID: 11887965
[TBL] [Abstract][Full Text] [Related]
5. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.
Rogawski MA
Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969
[TBL] [Abstract][Full Text] [Related]
6. The pharmacogenomics of epilepsy.
Franco V; Perucca E
Expert Rev Neurother; 2015 Oct; 15(10):1161-70. PubMed ID: 26327193
[TBL] [Abstract][Full Text] [Related]
7. Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.
Piana C; Antunes Nde J; Della Pasqua O
Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):341-58. PubMed ID: 24460510
[TBL] [Abstract][Full Text] [Related]
8. The potential of pharmacogenetics in the treatment of epilepsy.
Depondt C
Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
Anderson GD
Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
[TBL] [Abstract][Full Text] [Related]
10. [Epilepsy pharmacogenetics : science or fiction?].
Depondt C
Med Sci (Paris); 2013 Feb; 29(2):189-93. PubMed ID: 23452606
[TBL] [Abstract][Full Text] [Related]
11. [Personalized medicine for epilepsy based on the pharmacogenomic testing].
Yoshida S; Sugawara T; Nishio T; Kaneko S
Brain Nerve; 2011 Apr; 63(4):295-9. PubMed ID: 21441631
[TBL] [Abstract][Full Text] [Related]
12. Update on pharmacogenetics in epilepsy: a brief review.
Szoeke CE; Newton M; Wood JM; Goldstein D; Berkovic SF; OBrien TJ; Sheffield LJ
Lancet Neurol; 2006 Feb; 5(2):189-96. PubMed ID: 16426995
[TBL] [Abstract][Full Text] [Related]
13. Antiepileptic drug pharmacogenetics.
Patsalos PN
Ther Drug Monit; 2000 Feb; 22(1):127-30. PubMed ID: 10688275
[TBL] [Abstract][Full Text] [Related]
14. The clinical impact of pharmacogenetics on the treatment of epilepsy.
Löscher W; Klotz U; Zimprich F; Schmidt D
Epilepsia; 2009 Jan; 50(1):1-23. PubMed ID: 18627414
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics in the treatment of epilepsy.
Clancy CE; Kass RS
Pharmacogenomics; 2003 Nov; 4(6):747-51. PubMed ID: 14596638
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics and epilepsy: the road ahead.
Cavalleri GL; McCormack M; Alhusaini S; Chaila E; Delanty N
Pharmacogenomics; 2011 Oct; 12(10):1429-47. PubMed ID: 22008048
[TBL] [Abstract][Full Text] [Related]
17. Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.
Depondt C; Shorvon SD
Pharmacogenomics; 2006 Jul; 7(5):731-45. PubMed ID: 16886898
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects.
Johannessen Landmark C; Johannessen SI; Patsalos PN
Expert Opin Drug Metab Toxicol; 2020 Mar; 16(3):227-238. PubMed ID: 32054370
[No Abstract] [Full Text] [Related]
19. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis.
Haerian BS; Roslan H; Raymond AA; Tan CT; Lim KS; Zulkifli SZ; Mohamed EH; Tan HJ; Mohamed Z
Seizure; 2010 Jul; 19(6):339-46. PubMed ID: 20605481
[TBL] [Abstract][Full Text] [Related]
20. Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy.
Orlandi A; Paolino MC; Striano P; Parisi P
Expert Opin Drug Metab Toxicol; 2018 May; 14(5):505-512. PubMed ID: 29804481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
